4.7 Article

Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030

Journal

ANNALS OF INTERNAL MEDICINE
Volume 168, Issue 12, Pages 866-+

Publisher

AMER COLL PHYSICIANS
DOI: 10.7326/M17-2499

Keywords

-

Funding

  1. Intramural Research Program of the National Cancer Institute
  2. SEER Program of the National Cancer Institute: Connecticut [HHSN261201300019I]
  3. SEER Program of the National Cancer Institute: New Jersey [HHSN261201300021I, N01-PC-2013-00021]
  4. National Program of Cancer Registries of the Center for Disease Control and Prevention: Colorado [NU58DP006347-01]
  5. National Program of Cancer Registries of the Center for Disease Control and Prevention: Georgia [5U58DP003875-01]
  6. National Program of Cancer Registries of the Center for Disease Control and Prevention: Maryland [5NU58DP003919-05-00]
  7. National Program of Cancer Registries of the Center for Disease Control and Prevention: Michigan [17NU58DP006334]
  8. National Program of Cancer Registries of the Center for Disease Control and Prevention: New Jersey [NU58/DP003931-05-00]
  9. National Program of Cancer Registries of the Center for Disease Control and Prevention: New York [U58/DP003879]
  10. National Program of Cancer Registries of the Center for Disease Control and Prevention: Texas [1NU58DP006308]
  11. state of New Jersey
  12. state of Maryland
  13. Maryland Cigarette Restitution Fund
  14. state of New York
  15. National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Colorado [NU62PS003960]
  16. National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Connecticut [5U62PS001005-05]
  17. National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Michigan [U62PS004011-02]
  18. National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: New Jersey [U62PS004001-2]

Ask authors/readers for more resources

Background: Persons living with HIV (PLWH) have an elevated risk for certain types of cancer. With modern antiretroviral therapy, PLWH are aging and cancer rates are changing. Objective: To project cancer incidence rates and burden (number of new cancer diagnoses) among adult PLWH in the United States through 2030. Design: Descriptive. Setting: HIV/AIDS Cancer Match Study to project cancer rates and HIV Optimization and Prevention Economics model to project HIV prevalence. Participants: HIV-infected adults. Measurements: Projected cancer rates and burden among HIV-infected adults in the United States by age during 2006 to 2030 for AIDS-defining cancer (ADC)-that is, Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer-and certain types of non-AIDS-defining cancer (NADC). All other cancer types were combined. Results: The proportion of adult PLWH in the United States aged 65 years or older is projected to increase from 8.5% in 2010 to 21.4% in 2030. Age-specific rates are projected to decrease through 2030 across age groups for Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer, lung cancer, Hodgkin lymphoma, and other cancer types combined, and among those aged 65 years or older for colon cancer. Prostate cancer rates are projected to increase. The estimated total cancer burden in PLWH will decrease from 8150 cases in 2010 (2730 of ADC and 5420 of NADC) to 6690 cases in 2030 (720 of ADC and 5980 of NADC). In 2030, prostate cancer (n = 1590) and lung cancer (n = 1030) are projected to be the most common cancer types. Limitation: Projections assume that current trends in cancer incidence rates, HIV transmission, and survival will continue. Conclusion: The cancer burden among PLWH is projected to shift, with prostate and lung cancer expected to emerge as the most common types by 2030. Cancer will remain an important comorbid condition, and expanded access to HIV therapies and cancer prevention, screening, and treatment is needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Life expectancy in older adults with advanced cancer: Evaluation of a geriatric assessment-based prognostic model

Jennifer L. Lund, Paul R. Duberstein, Kah Poh Loh, Nikesha Gilmore, Sandy Plumb, Lianlian Lei, Alexander P. Keil, Jessica Y. Islam, Laura C. Hanson, Jeffrey K. Giguere, Victor G. Vogel, Brian L. Burnette, Supriya G. Mohile

Summary: This study developed a prognostic model for older adults with advanced cancer based on geriatric assessment and compared its performance to alternative models. The results showed that the geriatric assessment model had moderate discrimination and improved calibration for survival prediction. Further research is needed to optimize the use of geriatric assessment-based prognostic models in older adults with advanced cancer.

JOURNAL OF GERIATRIC ONCOLOGY (2022)

Article Oncology

Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy

Kea Turner, Naomi C. Brownstein, Zachary Thompson, Issam El Naqa, Yi Luo, Heather S. L. Jim, Dana E. Rollison, Rachel Howard, Desmond Zeng, Stephen A. Rosenberg, Bradford Perez, Andreas Saltos, Laura B. Oswald, Brian D. Gonzalez, Jessica Y. Islam, Amir Alishahi Tabriz, Wenbin Zhang, Thomas J. Dilling

Summary: The objective of this study was to investigate the association between longitudinal changes in patient-reported outcomes (PROs) and survival among early-stage non-small cell lung cancer (NSCLC) patients undergoing stereotactic body radiation therapy (SBRT). The results showed that longitudinal changes in ESAS scores were significantly associated with worse survival, and other factors including age, tumor diameter, gender, and smoking status were also significantly associated with worse survival.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Infectious Diseases

High-Risk Human Papillomavirus Messenger RNA Testing Using Urine, Cervicovaginal Self-Collected and Provider-Collected Cervical Samples Among Women in Mombasa, Kenya

Brigid K. Grabert, Jessica Y. Islam, Michael Mutua, Emmanuel Kabare, Griffins Manguro, Wairimu Waweru, Kishor Mandaliya, Juma Shafi, R. Scott McClelland, Jennifer S. Smith

Summary: Among females engaged in sex work in Kenya, urine self-collection is considered a comfortable and acceptable method for detecting human papillomavirus. However, detection of high-grade cervical cytology was less likely in urine samples compared to self- and provider-collected cervical samples.

SEXUALLY TRANSMITTED DISEASES (2022)

Article Respiratory System

Respiratory and allergic outcomes among 5-year-old children exposed to pesticides

Jessica Y. Islam, Jane Hoppin, Ana M. Mora, Manuel E. Soto-Martinez, Leonel Cordoba Gamboa, Jorge Ernesto Penaloza Castaneda, Brian Reich, Christian Lindh, Berna van Wendel de Joode

Summary: This study evaluated the effects of pesticide exposure on respiratory and allergic outcomes in children. By measuring urinary metabolite concentrations and collecting medical history information, it was found that pesticide exposure was associated with respiratory and allergic symptoms.

THORAX (2023)

Article Immunology

Individual-level factors associated with COVID-19 vaccine acceptance among US patients with cancer

Cassandra A. Hathaway, Erin M. Siegel, Brian D. Gonzalez, Laura B. Oswald, Anita R. Peoples, Cornelia M. Ulrich, Frank J. Penedo, Shelley S. Tworoger, Jessica Y. Islam

Summary: Most cancer patients are willing to receive the COVID-19 vaccine. Those willing to accept the vaccine have more confidence in its effectiveness and safety. Older individuals, those with greater perceived severity of COVID-19 infection, practicing more risk mitigation behaviors, and a history of receiving the flu shot are more likely to accept the vaccine.

VACCINE (2022)

Article Ophthalmology

COVID-19 Vaccination Rates Among US Adults With Vision or Hearing Disabilities

Kea Turner, Oliver T. Nguyen, Amir Alishahi Tabriz, Jessica Y. Islam, Young-Rock Hong

Summary: This study assessed the prevalence and factors of COVID-19 vaccination among US adults with vision or hearing disabilities. The study found that adults with vision or hearing disabilities had lower vaccination rates compared to adults without disabilities. These findings are important for promoting equitable and accessible vaccination.

JAMA OPHTHALMOLOGY (2022)

Article Oncology

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih-Yuan Hsu, Saif Alimohamed, Babar Bashir, Stephanie Berg, Mehmet A. Bilen, Daniel Bowles, Cecilia Castellano, Aakash Desai, Arielle Elkrief, Omar E. Eton, Leslie A. Fecher, Daniel Flora, Matthew D. Galsky, Margaret E. Gatti-Mays, Alicia Gesenhues, Michael J. Glover, Dharmesh Gopalakrishnan, Shilpa Gupta, Thorvardur R. Halfdanarson, Brandon Hayes-Lattin, Mohamed Hendawi, Emily Hsu, Clara Hwang, Roman Jandarov, Chinmay Jani, Douglas B. Johnson, Monika Joshi, Hina Khan, Shaheer A. Khan, Natalie Knox, Vadim S. Koshkin, Amit A. Kulkarni, Daniel H. Kwon, Sara Matar, Rana R. McKay, Sanjay Mishra, Feras A. Moria, Amanda Nizam, Nora L. Nock, Taylor K. Nonato, Justin Panasci, Lauren Pomerantz, Andrew J. Portuguese, Destie Provenzano, Matthew Puc, Yuan J. Rao, Terence D. Rhodes, Gregory J. Riely, Jacob J. Ripp, Andrea Rivera, Erika Ruiz-Garcia, Andrew L. Schmidt, Adam J. Schoenfeld, Gary K. Schwartz, Sumit A. Shah, Justin Shaya, Suki Subbiah, Lisa M. Tachiki, Matthew D. Tucker, Melissa Valdez-Reyes, Lisa B. Weissmann, Michael T. Wotman, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Yuanchu James Yang, Michael A. Thompson, Dimpy P. Shah, Jeremy L. Warner, Yu Shyr, Toni K. Choueiri, Trisha M. Wise-Draper

Summary: This cohort study found that systemic anticancer therapies, especially IO, in the context of baseline immunosuppression, were associated with severe clinical outcomes and the development of cytokine storm in patients with cancer and COVID-19.

JAMA ONCOLOGY (2023)

Editorial Material Oncology

Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Nathaniel B. Verhagen, Nicolas K. Koerber, Aniko Szabo, Bradley Taylor, J. Njeri Wainaina, Douglas B. Evans, Anai N. Kothari

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Racial and ethnic inequities of palliative care use among advanced Non-Small cell lung cancer patients in the US

Jessica Y. Islam, Dejana Braithwaite, Dongyu Zhang, Yi Guo, Tina D. Tailor, Tomi Akinyemiju

Summary: This study found that white and indigenous patients with non-small cell lung cancer are more likely to receive palliative care, while black and Hispanic/Latinx patients are less likely. In addition, the type of health insurance also affects the utilization of palliative care.

CANCER MEDICINE (2023)

Article Oncology

Oncology Providers' and Professionals' Experiences With Suicide Risk Screening Among Patients With Head and Neck Cancer: A Qualitative Study

Kea Turner, Angela M. Stover, Danielle B. Tometich, Carley Geiss, Arianna Mason, Oliver T. Nguyen, Emma Hume, Rachael McCormick, Sean Powell, Julie Hallanger-Johnson, Krupal B. Patel, Kedar S. Kirtane, Neelima Jammigumpula, Colin Moore, Randa Perkins, Dana E. Rollison, Heather S. L. Jim, Laura B. Oswald, Sylvia Crowder, Brian D. Gonzalez, Edmondo Robinson, Amir Alishahi Tabriz, Jessica Y. Islam, Scott M. Gilbert

Summary: This study assessed the perspectives of oncology providers and professionals on the barriers and facilitators of implementing suicide risk screening for patients with head and neck cancer. Multilevel implementation barriers were identified, such as patient difficulty with using a tablet, limited nursing engagement, limited clinic Wi-Fi connectivity, and low clinician self-efficacy for interpreting and acting upon patient-reported outcome scores. Participants recommended strengthening patient and clinician education and providing alternative data entry modalities for patients.

JCO ONCOLOGY PRACTICE (2023)

Article Public, Environmental & Occupational Health

Impact of the COVID-19 pandemic on human papillomavirus (HPV) vaccination among a national sample of United States adults ages 18-45: A cross-sectional study

Kea Turner, Naomi C. Brownstein, Junmin Whiting, Mariana Arevalo, Susan Vadaparampil, Anna R. Giuliano, Jessica Y. Islam, Cathy D. Meade, Clement K. Gwede, Monica L. Kasting, Katharine J. Head, Shannon M. Christy

Summary: This study examined the impact of the COVID-19 pandemic on catch-up HPV vaccination among adults aged 18-45 in the US. The results showed that 8.6% of adults intending to get the HPV vaccine experienced pandemic-related vaccination disruption, with 14.7% reporting uncertainty about the disruption. Factors associated with a higher likelihood of disruption included non-English language preference, being a parent/guardian, healthcare visits in the past year, up-to-date tetanus vaccination, and being a cancer survivor.

PREVENTIVE MEDICINE REPORTS (2023)

Article Immunology

Lung Cancer Screening Adherence Among People with HIV Treated at an Integrated Health System in Florida

Jessica Y. Islam, Shuang Yang, Matthew Schabath, Susan T. Vadaparampil, Xiwei Lou, Yonghui Wu, Jiang Bian, Yi Guo

Summary: We evaluated the adherence to low-dose computed tomography (LDCT) among people with HIV (PWH) treated at University of Florida (UF). Out of the identified PWH who underwent at least one LDCT procedure, only 12% were adherent to LDCT. Poor adherence to lung cancer screening was observed, with only 25% of PWH diagnosed with category 4A being adherent.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2023)

Article Oncology

Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18-26 and 27-45 years in the United States: A cross-sectional study

Mariana Arevalo, Naomi C. Brownstein, Junmin Whiting, Susan T. Vadaparampil, Katharine J. Head, Cathy D. Meade, Jessica Y. Islam, Monica L. Kasting, Clement K. Gwede, Veronica Barrios-Monroy, Shannon M. Christy

Summary: The study examined the self-reported HPV vaccination uptake and intentions among US adults aged 18 to 26 and 27 to 45 years. It found that factors such as provider recommendation and positive attitudes towards the vaccine were associated with vaccination uptake. However, there was a low intention to receive the HPV vaccine in the next year among those who did not report prior vaccination. Targeted interventions are needed to improve vaccination rates in these age groups.

CANCER (2023)

Article Oncology

Cancer treatment delays among cancer patients living with HIV during the COVID-19 pandemic in the United States

Ashley Khouri, Jessica Y. Islam, Nathan W. Van Bibber, Anna E. Coghill, Gita Suneja

Summary: This study aimed to compare delays in cancer treatment initiation between people living with HIV (PLWH) and cancer, the general cancer population (GCP), and patients with cancer and a history of solid organ transplant (SOT). The study found that during the COVID-19 pandemic, PLWH experienced significant delays in cancer treatment initiation, which may negatively impact cancer outcomes.

CANCER MEDICINE (2023)

Article Public, Environmental & Occupational Health

Lung cancer screening adherence among people living with and without HIV: An analysis of an integrated health system in Florida, United States (2012-2021)

Jessica Y. Islam, Shuang Yang, Matthew Schabath, Susan T. Vadaparampil, Xiwei Lou, Yonghui Wu, Jiang Bian, Yi Guo

Summary: Although lung cancer is a leading cause of death among people living with HIV (PLWH), limited research exists characterizing real-world lung cancer screening adherence among PLWH. Our study found that PLWH have poorer adherence to LDCT screenings compared to their HIV-negative counterparts.

PREVENTIVE MEDICINE REPORTS (2023)

No Data Available